Suppr超能文献

布鲁顿酪氨酸激酶缺陷小鼠B细胞中Toll样受体9介导的细胞因子产生缺陷。

Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.

作者信息

Hasan Maroof, Lopez-Herrera Gabriela, Blomberg K Emelie M, Lindvall Jessica M, Berglöf Anna, Smith C I Edvard, Vargas Leonardo

机构信息

Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Immunology. 2008 Feb;123(2):239-49. doi: 10.1111/j.1365-2567.2007.02693.x. Epub 2007 Aug 28.

Abstract

Bruton's tyrosine kinase (Btk), a member of the Tec family of tyrosine kinases, plays an important role in the differentiation and activation of B cells. Mutations affecting Btk cause immunodeficiency in both humans and mice. In this study we set out to investigate the potential role of Btk in Toll-like receptor 9 (TLR9) activation and the production of pro-inflammatory cytokines such as interleukin (IL)-6, tumour necrosis factor (TNF)-alpha and IL-12p40. Our data show that Btk-deficient B cells respond more efficiently to CpG-DNA stimulation, producing significantly higher levels of pro-inflammatory cytokines but lower levels of the inhibitory cytokine IL-10. The quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis presented in this work shows that mRNA production of one of the important new members of the IL-12 family, IL-27, was significantly increased in Btk-deficient B cells after CpG-DNA stimulation. In this study, we demonstrate significant differences in CpG responsiveness between transitional 1 (T1) and T2 B cells for survival and maturation. Furthermore, TLR9 expression, measured both as protein and as mRNA, was increased in Btk-defective cells, especially after TLR9 stimulation. Collectively, these data provide evidence in support of the theory that Btk regulates both TLR9 activation and expression in mouse splenic B cells.

摘要

布鲁顿酪氨酸激酶(Btk)是酪氨酸激酶Tec家族的成员之一,在B细胞的分化和激活中发挥重要作用。影响Btk的突变会导致人类和小鼠出现免疫缺陷。在本研究中,我们着手探究Btk在Toll样受体9(TLR9)激活以及促炎细胞因子如白细胞介素(IL)-6、肿瘤坏死因子(TNF)-α和IL-12p40产生过程中的潜在作用。我们的数据表明,缺乏Btk的B细胞对CpG-DNA刺激反应更有效,产生的促炎细胞因子水平显著更高,但抑制性细胞因子IL-10的水平更低。本研究中进行的定量逆转录-聚合酶链反应(RT-PCR)分析表明,在CpG-DNA刺激后,IL-12家族的重要新成员之一IL-27在缺乏Btk的B细胞中的mRNA产生显著增加。在本研究中,我们证明了过渡1(T1)和T2 B细胞在存活和成熟方面对CpG反应性存在显著差异。此外,无论是蛋白质还是mRNA水平,在有缺陷的Btk细胞中TLR9表达均增加,尤其是在TLR9刺激后。总的来说,这些数据为Btk调节小鼠脾脏B细胞中TLR9激活和表达这一理论提供了证据支持。

相似文献

1
Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.
Immunology. 2008 Feb;123(2):239-49. doi: 10.1111/j.1365-2567.2007.02693.x. Epub 2007 Aug 28.
3
Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Front Immunol. 2019 Jan 30;10:95. doi: 10.3389/fimmu.2019.00095. eCollection 2019.
4
Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
Mol Immunol. 2009 Jun;46(10):1970-8. doi: 10.1016/j.molimm.2009.03.010. Epub 2009 Apr 10.
5
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation.
J Allergy Clin Immunol. 2014 Jun;133(6):1644-50.e4. doi: 10.1016/j.jaci.2013.12.1085. Epub 2014 Mar 4.
7
Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Eur J Immunol. 2014 Apr;44(4):1130-6. doi: 10.1002/eji.201344030. Epub 2014 Jan 20.
8
Bruton's tyrosine kinase is required for TLR-induced IL-10 production.
J Immunol. 2006 Nov 15;177(10):7203-10. doi: 10.4049/jimmunol.177.10.7203.
9
Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
Mol Immunol. 2008 Dec;46(2):233-41. doi: 10.1016/j.molimm.2008.08.278. Epub 2008 Oct 11.

引用本文的文献

1
Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer.
Front Immunol. 2021 Nov 22;12:763791. doi: 10.3389/fimmu.2021.763791. eCollection 2021.
2
The Role of α7nAChR-Mediated Cholinergic Anti-inflammatory Pathway in Immune Cells.
Inflammation. 2021 Jun;44(3):821-834. doi: 10.1007/s10753-020-01396-6. Epub 2021 Jan 6.
5
Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.
Front Immunol. 2018 Apr 4;9:683. doi: 10.3389/fimmu.2018.00683. eCollection 2018.
6
Bruton's tyrosine kinase regulates TLR7/8-induced TNF transcription via nuclear factor-κB recruitment.
Biochem Biophys Res Commun. 2018 May 5;499(2):260-266. doi: 10.1016/j.bbrc.2018.03.140. Epub 2018 Mar 22.
7
First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL.
Oncotarget. 2018 Jan 22;9(16):13023-13035. doi: 10.18632/oncotarget.24310. eCollection 2018 Feb 27.
8
Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.
JCI Insight. 2018 Mar 8;3(5):96795. doi: 10.1172/jci.insight.96795.
9
The Toll-like receptor 9 signalling pathway regulates MR1-mediated bacterial antigen presentation in B cells.
Immunology. 2017 Oct;152(2):232-242. doi: 10.1111/imm.12759. Epub 2017 Jun 29.
10
Functional role of the nicotinic arm of the acetylcholine regulatory axis in human B-cell lines.
J Exp Pharmacol. 2009 Nov 3;1:1-7. doi: 10.2147/jep.s7055. eCollection 2009.

本文引用的文献

1
Bruton's tyrosine kinase is required for TLR-induced IL-10 production.
J Immunol. 2006 Nov 15;177(10):7203-10. doi: 10.4049/jimmunol.177.10.7203.
2
TLR9 in health and disease.
Int Rev Immunol. 2006 May-Aug;25(3-4):155-81. doi: 10.1080/08830180600743107.
5
Differential effects of IL-27 on human B cell subsets.
J Immunol. 2006 May 15;176(10):5890-7. doi: 10.4049/jimmunol.176.10.5890.
6
Toll-like receptor stimulation as a third signal required for activation of human naive B cells.
Eur J Immunol. 2006 Apr;36(4):810-6. doi: 10.1002/eji.200535744.
7
Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production.
J Immunol. 2006 Mar 15;176(6):3635-41. doi: 10.4049/jimmunol.176.6.3635.
8
MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction.
J Biol Chem. 2006 Apr 14;281(15):10489-95. doi: 10.1074/jbc.M508892200. Epub 2006 Jan 26.
9
TLR9 activation is defective in common variable immune deficiency.
J Immunol. 2006 Feb 1;176(3):1978-87. doi: 10.4049/jimmunol.176.3.1978.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验